Geode Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.3M | Buy |
1,712,931
+66,394
| +4% | +$2.41M | ﹤0.01% | 1310 |
|
|
2025
Q1 | $59.6M | Buy |
1,646,537
+83,747
| +5% | +$3.03M | ﹤0.01% | 1276 |
|
|
2024
Q4 | $65.8M | Sell |
1,562,790
-8,291
| -0.5% | -$349K | 0.01% | 1255 |
|
|
2024
Q3 | $87.3M | Buy |
1,571,081
+65,623
| +4% | +$3.65M | 0.01% | 1077 |
|
|
2024
Q2 | $61.9M | Buy |
1,505,458
+165,632
| +12% | +$6.81M | 0.01% | 1211 |
|
|
2024
Q1 | $62.6M | Buy |
1,339,826
+56,204
| +4% | +$2.62M | 0.01% | 1198 |
|
|
2023
Q4 | $61.4M | Buy |
1,283,622
+200,335
| +18% | +$9.58M | 0.01% | 1213 |
|
|
2023
Q3 | $38.6M | Buy |
1,083,287
+22,674
| +2% | +$808K | ﹤0.01% | 1399 |
|
|
2023
Q2 | $48.9M | Buy |
1,060,613
+45,973
| +5% | +$2.12M | 0.01% | 1265 |
|
|
2023
Q1 | $40.7M | Buy |
1,014,640
+31,610
| +3% | +$1.27M | 0.01% | 1335 |
|
|
2022
Q4 | $45.5M | Buy |
983,030
+58,153
| +6% | +$2.69M | 0.01% | 1219 |
|
|
2022
Q3 | $38.3M | Buy |
924,877
+16,164
| +2% | +$669K | 0.01% | 1277 |
|
|
2022
Q2 | $54.2M | Buy |
908,713
+5,813
| +0.6% | +$347K | 0.01% | 1052 |
|
|
2022
Q1 | $65.6M | Buy |
902,900
+25,944
| +3% | +$1.88M | 0.01% | 1055 |
|
|
2021
Q4 | $73.7M | Buy |
876,956
+30,889
| +4% | +$2.6M | 0.01% | 1009 |
|
|
2021
Q3 | $76.3M | Buy |
846,067
+30,868
| +4% | +$2.78M | 0.01% | 969 |
|
|
2021
Q2 | $77.7M | Sell |
815,199
-261,334
| -24% | -$24.9M | 0.01% | 954 |
|
|
2021
Q1 | $123M | Buy |
1,076,533
+99,514
| +10% | +$11.3M | 0.02% | 663 |
|
|
2020
Q4 | $135M | Buy |
977,019
+118,222
| +14% | +$16.4M | 0.02% | 584 |
|
|
2020
Q3 | $70.6M | Buy |
858,797
+995
| +0.1% | +$81.8K | 0.01% | 747 |
|
|
2020
Q2 | $67.1M | Buy |
857,802
+40,827
| +5% | +$3.19M | 0.01% | 733 |
|
|
2020
Q1 | $36.3M | Buy |
816,975
+72,120
| +10% | +$3.2M | 0.01% | 933 |
|
|
2019
Q4 | $31.8M | Buy |
744,855
+13,176
| +2% | +$563K | 0.01% | 1244 |
|
|
2019
Q3 | $31.3M | Buy |
731,679
+7,390
| +1% | +$316K | 0.01% | 1172 |
|
|
2019
Q2 | $46M | Buy |
724,289
+53,043
| +8% | +$3.37M | 0.01% | 917 |
|
|
2019
Q1 | $46.6M | Buy |
671,246
+103,016
| +18% | +$7.14M | 0.01% | 879 |
|
|
2018
Q4 | $24.7M | Buy |
568,230
+63,118
| +12% | +$2.74M | 0.01% | 1141 |
|
|
2018
Q3 | $38.6M | Buy |
505,112
+25,598
| +5% | +$1.95M | 0.01% | 966 |
|
|
2018
Q2 | $36.9M | Buy |
479,514
+44,442
| +10% | +$3.42M | 0.01% | 939 |
|
|
2018
Q1 | $22.2M | Buy |
435,072
+71,882
| +20% | +$3.67M | 0.01% | 1190 |
|
|
2017
Q4 | $16.8M | Sell |
363,190
-419
| -0.1% | -$19.4K | 0.01% | 1388 |
|
|
2017
Q3 | $19.4M | Buy |
363,609
+15,370
| +4% | +$819K | 0.01% | 1264 |
|
|
2017
Q2 | $21.6M | Buy |
348,239
+14,515
| +4% | +$902K | 0.01% | 1118 |
|
|
2017
Q1 | $22.6M | Buy |
333,724
+34,956
| +12% | +$2.37M | 0.01% | 1049 |
|
|
2016
Q4 | $21M | Buy |
298,768
+24,529
| +9% | +$1.72M | 0.01% | 1053 |
|
|
2016
Q3 | $19.5M | Buy |
274,239
+11,018
| +4% | +$782K | 0.01% | 1026 |
|
|
2016
Q2 | $12.9M | Buy |
263,221
+5,508
| +2% | +$269K | 0.01% | 1243 |
|
|
2016
Q1 | $16.3K | Buy |
257,713
+9,987
| +4% | +$632 | 0.01% | 1046 |
|
|
2015
Q4 | $27.8M | Buy |
247,726
+10,287
| +4% | +$1.15M | 0.02% | 730 |
|
|
2015
Q3 | $22.9M | Buy |
237,439
+48,140
| +25% | +$4.64M | 0.01% | 811 |
|
|
2015
Q2 | $19.4M | Buy |
189,299
+49,450
| +35% | +$5.06M | 0.01% | 953 |
|
|
2015
Q1 | $8.68M | Buy |
139,849
+16,985
| +14% | +$1.05M | 0.01% | 1497 |
|
|
2014
Q4 | $5.39M | Sell |
122,864
-2,292
| -2% | -$101K | ﹤0.01% | 1765 |
|
|
2014
Q3 | $7.08M | Buy |
125,156
+88,416
| +241% | +$5M | ﹤0.01% | 1527 |
|
|
2014
Q2 | $1.65M | Buy |
36,740
+778
| +2% | +$34.9K | ﹤0.01% | 2500 |
|
|
2014
Q1 | $1.76M | Buy |
+35,962
| New | +$1.76M | ﹤0.01% | 2414 |
|